Sfoglia per AUTORE
BORGHI V
Collezione ASL Città di Torino

  

Items : 11

VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Digestive and Liver Disease

2020
ASL Città di Torino

Ceccherini-Silberstein F; Craxì A; Perno CF; Angelico M; Andreoni M; Zazzi M; Raimondo G; Puoti M; Gaeta GB; Baldanti F; Coppola N; Parruti G; Lampertico P; Ghisetti V; Beretta I; Cariti G; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Giorgini A; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Giannelli V; Rizzardini G; Ganga R; et alii...

Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2019 Nov;25(11):1443-1446. doi: 10.1016/j.cmi.2019.07.004. Epub 2019 Jul 25.

2019
ASL Città di Torino
ASL VCO
AOU Novara

Di Biagio A; Bonora S; Monno L; Paolini E; Callegaro AP; Zoncada A; Pecorari M; Francisci D; Borghi V; Galli L; Vicenti I; Bruzzone B; Taramasso L; Ungaro R;

Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience in Journal of Hepatology

2019
ASL Città di Torino

Francesca Ceccherini S; Mario A; Federico Perno C; Andreoni M; Craxi A; Raimondo G; Zazzi M; Nicola C; Parruti G; Pellicelli A; Lampertico P; Rizzardini G; Ganga R; Puoti M; Paternoster C; Taliani G; Santantonio T; Babudieri S; De Santis A; Lichtner M; Cozzolongo R; Brunetto M; Borghi V; Rita Maida I; Morsica G; Sangiovanni V; Cuomo N; Ciancio A; Andreone P; et alii...

Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experience in Digestive and Liver Disease

2019
ASL Città di Torino

Ceccherini-Silberstein F; Perno CF; Craxì A; Angelico M; Andreoni M; Raimondo G; Zazzi M; Coppola N; Parruti G; Giorgini A; Lampertico P; Di Lorenzo F; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Santantonio T; Di Stefano M; Taliani G; Babudieri S; Lichtner M; De Santis A; Cozzolongo R; Colombatto P; Brunetto M; et alii...

Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance in Digestive and Liver Disease

2019
ASL Città di Torino

Perno CF; Ceccherini-Silberstein F; Craxì A; Andreoni M; Baldanti F; Angelico M; Pasquazzi C; Parruti G; Lampertico P; Taliani G; Babudieri S; Rizzardini G; Pellicelli A; Puoti M; Paba P; Sarmati L; Borghi V; Lichtner M; Guarneri V; Siciliano M; Morisco F; Iapadre N; Maserati R; Bonora S; Micheli V; Boccaccio V; Galli S; Magni CF; Campoli R; et alii...

Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology

2019
ASL Città di Torino

Silberstein FC; Perno CF; Mario A; Andreoni M; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Babudieri S; Pellicelli A; Craxi A; Sarmati L; Puoti M; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Bonora S; Iapadre N; Maserati R; Boccaccio V; Micheli V; Galli S; Magni CF; Campoli R; Borghi V; Nicolini LA; et alii...

Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology

2019
ASL Città di Torino

Ceccherini Silberstein F; Federico Perno C; Andreoni M; Mario A; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Pellicelli A; Babudieri S; Craxi A; Puoti M; Sarmati L; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Iapadre N; Bonora S; Maserati R; Boccaccio V; Micheli V; Federico Magni C; Galli S; Campoli R; Borghi V; Ambra Nicolini L; et alii...

Decline of prevalence of resistance associated substitutions to NS3 and NS5A inhibitors at DAA failure in hepatitis C virus in Italy over the years 2015 to 2018 in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Zazzi M; Craxì A; Federico Perno C; Angelico M; Andreoni M; Rizzardini G; Raimondo G; Battista Gaeta G; Lampertico P; Babudieri S; Caudai C; Cuomo N; Santantonio TA; Pollicino T; Brunetto MR; Andreone P; Borghi V; Aghemo A; Ciancio A; Cariti G; Giorgini A; Palitti VP; Ciaccio A; Licata A; Lenci I; Biolato M; Sangiovanni V; Prestileo T; et alii...

Italian real life experience of resistanceguided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen in Hepatology v70 suppl.1 2019

2019
ASL Città di Torino

Silberstein FC; Perno CF; Craxì A; Angelico M; Andreoni M; Zazzi M; Raimondo G; Coppola N; Parruti G; Lampertico P; Beretta I; Rossetti B; Lleo A; Dentone C; Sighinolfi L; Di Lorenzo F; Giorgini A; Licata A; Mastroianni C; Milano E; Pellicelli A; Rizzardini G; Ganga R; Puoti M; Paternoster C; Di Stefano M; Santantonio TA; Taliani G; Biliotti E; et alii...

Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients. in PloS one / PLoS One. 2018 Feb 20;13(2):e0192627. doi: 10.1371/journal.pone.0192627. eCollection 2018.

2018
ASL Città di Torino
AOU Città della Salute di Torino

Segala D; Teti E; Taramasso L; Di Biagio A; Bovis F; Nicolini LA; Antinori A; Milazzo L; Chirianni A; Vullo V; Parruti G; Giacometti A; Cacopardo B; Boffa N; Gori A; Spinetti A; Puoti M; Pasquazzi C; Di Perri G; Mastroianni C; Bruno R; Borghi V; Montagnani F; Cattelan A; Hasson H; Taliani G; D'Arminio Monforte A; Bigoni S; Saracino A; et alii...

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2017 Mar 1;64(5):680-683. doi: 10.1093/cid/ciw846. Epub 2016 Dec 22.

2017
ASL Città di Torino
AOU Città della Salute di Torino

Massimo A; Teti E; Pasquazzi C; Pennica A; Chirianni A; Vullo V; Parruti G; Giacometti A; Bruno C; Boffa N; Gori A; Spinetti A; Puoti M; Bigoni S; Di Perri G; Mastroianni CM; Monforte AD; Taliani G; Hasson H; Cattelan A; De Luca A; Borghi V; Saracino A; Bruno R; Di Biagio A; Rizzardini G; Sollima S; Milazzoi L; Antinori A; et alii...